NCT06680934 CABP2 Patient Registry and Natural History Study
| NCT ID | NCT06680934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Goettingen |
| Condition | CABP2-related Auditory Synaptopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-08-16 |
| Primary Completion | 2049-08-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-08-16 with a primary completion date of 2049-08-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.
Eligibility Criteria
Inclusion Criteria: * A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry Exclusion Criteria: * Patients with evidence of non-CABP2 molecular genetic diagnoses
Contact & Investigator
Tobias Moser, MD
STUDY DIRECTOR
University Medical Center Goettingen
Frequently Asked Questions
Who can join the NCT06680934 clinical trial?
This trial is open to participants of all sexes, studying CABP2-related Auditory Synaptopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06680934 currently recruiting?
Yes, NCT06680934 is actively recruiting participants. Contact the research team at barbara.vona@med.uni-goettingen.de for enrollment information.
Where is the NCT06680934 trial being conducted?
This trial is being conducted at Göttingen, Germany.
Who is sponsoring the NCT06680934 clinical trial?
NCT06680934 is sponsored by University Medical Center Goettingen. The principal investigator is Tobias Moser, MD at University Medical Center Goettingen. The trial plans to enroll 100 participants.